Laboratory assessment of rivaroxaban: a review

Research into new anticoagulants for preventing and treating thromboembolic disorders has focused on targeting single enzymes in the coagulation cascade, particularly Factor Xa and thrombin, inhibition of which greatly decreases thrombin generation. Based on the results of phase III clinical trials,...

Descripción completa

Detalles Bibliográficos
Autores principales: Samama, Meyer Michel, Contant, Geneviève, Spiro, Theodore E, Perzborn, Elisabeth, Le Flem, Lena, Guinet, Céline, Gourmelin, Yves, Rohde, Gabriele, Martinoli, Jean-Luc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726412/
https://www.ncbi.nlm.nih.gov/pubmed/23822763
http://dx.doi.org/10.1186/1477-9560-11-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726412/
https://www.ncbi.nlm.nih.gov/pubmed/23822763
http://dx.doi.org/10.1186/1477-9560-11-11

Ejemplares similares